Interleukin-15 stimulates macrophages to activate CD4 + T cells: a role in the pathogenesis of rheumatoid arthritis?Introduction ) is expressed in a wide variety of cell types, including fibroblasts, keratinocytes, epithelial cells, osteoclasts and activated monocytes. It is also produced by haematopoietic progenitors and bone marrow stromal cells 1 and by differentiated antigen-presenting cells and phagocytes, such as dendritic cells (DCs) and macrophages (MF). 2 We have reported that interaction between IL-15 and the IL-15 receptor a (IL-15Ra) in DCs is critical for maturation and antigen presentation to T cells. 3,4 Studies with IL-15Ra )/) and IL-15 )/) mice show that IL-15 is an essential cytokine for the development and survival of natural killer (NK) cells, NK T cells, and memory and activated CD8 + T cells. Interleukin-15 is a potent proinflammatory cytokine that induces, for example, tumour necrosis factor-a (TNF-a), IL-1b and inflammatory chemokines. It inhibits self-tolerance and facilitates the maintenance of memory T-cell survival, including that of self-directed cells. Deregulated IL-15 expression has been reported in patients with an array of inflammatory autoimmune diseases.
SummaryInterleukin-15 (IL-15) is a proinflammatory cytokine that is overexpressed in rheumatoid arthritis (RA), a disease characterized by activation of monocytes/macrophages (MF), and by expansion of autoreactive CD4 + T cells. We hypothesized that IL-15 plays a major role for this expansion of CD4 + T cells and modulates the phenotype of monocytes/MF and their interaction with CD4 + T cells. Here, we show that IL-15 enhances the proliferation of CD4 + T cells from patients with RA in peripheral blood mononuclear cell cocultures. To further dissect the underlying mechanisms, we employed MF from IL-15 )/) or IL-15 transgenic mice. These were induced to differentiate or were stimulated with IL-15. Here we show that addition of IL-15 during differentiation of MF (into 'IL-15MF') and overexpression of IL-15 by MF from IL-15 tg mice leads to increased levels of major histocompatibility complex class II expression. This resulted in enhanced stimulation of antigen-specific CD4 + T cells in vitro and was accompanied by reduced messenger RNA expression in MF for immunosuppressive SOCS3. The proliferation rates of IL-15MF and IL-15 tg MF were high, which was reflected by increased p27 Kip1 and reduced p21 Waf1 levels. In view of high serum and synovial levels of IL-15 in patients with RA, our data suggest the possibility that this excess IL-15 in RA may stimulate monocytes/MF to activate the characteristic autoreactive CD4 + T cells in RA.